rtki cpd and pd 0325901

rtki cpd has been researched along with pd 0325901 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, G; Hossain, MM; Hu, B; Meng, X; Sun, Y; Zhang, X	1

Other Studies

1 other study(ies) available for rtki cpd and pd 0325901

Article	Year
ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation. International journal of oncology, 2016, Volume: 49, Issue:2 Topics: ADAM17 Protein; Animals; Benzamides; Breast Neoplasms; Chromones; Diphenylamine; ErbB Receptors; Female; Humans; MCF-7 Cells; Mice; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA, Small Interfering; Signal Transduction; Tyrphostins; Xenograft Model Antitumor Assays	2016

Article

Year

ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.

International journal of oncology, 2016, Volume: 49, Issue:2

Topics: ADAM17 Protein; Animals; Benzamides; Breast Neoplasms; Chromones; Diphenylamine; ErbB Receptors; Female; Humans; MCF-7 Cells; Mice; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA, Small Interfering; Signal Transduction; Tyrphostins; Xenograft Model Antitumor Assays

2016